Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Quantum Biopharma Ltd. (QNTM) had Return on Tangible Equity of -4573.55% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.18M |
|
-- |
|
-- |
|
$15.30M |
|
$-15.30M |
|
$-11.65M |
|
$-26.96M |
|
$-27.39M |
|
$-26.96M |
|
$-26.96M |
|
$-26.96M |
|
$-27.39M |
|
$-15.30M |
|
$-14.76M |
|
3.29M |
|
3.29M |
|
$-8.20 |
|
$-8.20 |
|
| Balance Sheet Financials | |
$6.48M |
|
$0.07M |
|
$4.68M |
|
$11.16M |
|
$6.06M |
|
-- |
|
-- |
|
$6.06M |
|
$5.10M |
|
$0.59M |
|
$5.10M |
|
3.89M |
|
| Cash Flow Statement Financials | |
$-8.24M |
|
$-1.95M |
|
$6.10M |
|
$6.00M |
|
$1.91M |
|
$-4.09M |
|
$2.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.07 |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-528.29% |
|
|
Return on Tangible Equity |
-4573.55% |
-241.53% |
|
-528.29% |
|
$1.31 |
|
$-2.51 |
|
$-2.51 |
|